Curing Coma: The Emerging Paradigm Shift

Traditional management of coma has largely emphasized passive physiological support and early prognostication, often reducing clinical trajectories to binary decisions of continued life support versus withdrawal of care. However, recent advances in neurobiology and neurotechnology, and global initiatives such as the “Curing Coma Campaign,” are driving a fundamental reconceptualization of coma, not as a static end state, but as a treatable, neuroplastic condition. India, with its absence of formal withdrawal-of-care legislation, offers a unique environment for prolonged observation of coma and the unexpected recovery trajectories. This article aims to highlight an evolving paradigm in coma care that advocates proactive diagnosis, targeted intervention, and culturally sensitive neurorehabilitation strategies, particularly in resource-limited settings. This narrative synthesis explores current literature, case-based observations, and emerging clinical frameworks that emphasize concepts such as coma endotyping, multimodal diagnostics, early neurorehabilitation, pharmacological awakening, and ethical contextualization. It underscores the relevance of tiered diagnostic pathways and longitudinal recovery models applicable to low-resource ICUs. Coma endotyping enables classification based on underlying mechanisms, reversibility, and the extent of structural disruption, thereby guiding therapeutic interventions. Emerging tools, such as electroencephalography (EEG)-based brain-computer interfaces, and pharmacological agents, such as amantadine and modafinil, show growing promise in facilitating recovery of consciousness. Observations from Indian ICUs, where prolonged life-sustaining care is common, reveal delayed but clinically meaningful recoveries, particularly in reversible etiologies such as autoimmune encephalitis and posterior reversible encephalopathy syndrome. Structured ICU-based neurorehabilitation and ethical frameworks aligned with familial and cultural values further enhance the potential for recovery. The time has come to shift from the paradigm of “coma management” to that of “coma cure.” This transition requires reimagining the ICU as an incubator for neurorecovery. In the Indian context, with global collaboration, there is potential to pioneer contextually appropriate coma care models that prioritize hope, time, and targeted therapy. Moving forward, integrated prognostic registries and region-specific awakening trials will be essential to redefine coma recovery standards worldwide.